1. Robert Plenge, M.D.

    0 Comments Leave a Comment

    1-1 of 1
    1. Mentioned In 1 Articles

    2. Translate Bio Appoints Robert Plenge, M.D., Ph.D., to its Board of Directors

      Translate Bio Appoints Robert Plenge, M.D., Ph.D., to its Board of Directors
      LEXINGTON, Mass., April 11, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced the appointment of Robert Plenge, M.D., Ph.D., vice president, research and early development and head of the Inflammation and Immunology Thematic Center of Excellence Unit at Celgene, to its Board ...
      Read Full Article
    3. 1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content